Alcaftadine: a topical antihistamine for use in allergic conjunctivitis.
@article{Namdar2011AlcaftadineAT, title={Alcaftadine: a topical antihistamine for use in allergic conjunctivitis.}, author={R. Namdar and C. Valdez}, journal={Drugs of today}, year={2011}, volume={47 12}, pages={ 883-90 } }
Alcaftadine (Lastacaft®; Allergen, Inc.) is a broad-spectrum antihistamine displaying a high affinity for histamine H1 and H2 receptors and a lower affinity for H4 receptors. It also exhibits modulatory action on immune cell recruitment and mast cell stabilizing effects. The authors reviewed all available English-language literature characterizing the efficacy, safety and pharmacokinetic profile of alcaftadine ophthalmic solution. In the studies reviewed, alcaftadine was more effective than… CONTINUE READING
Topics from this paper
18 Citations
Update and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitis
- Medicine
- Clinical ophthalmology
- 2015
- 16
- PDF
Ocular itch associated with allergic conjunctivitis: latest evidence and clinical management
- Medicine
- Therapeutic advances in chronic disease
- 2016
- 29
- Highly Influenced
Ocular Itch Relief with Alcaftadine 0.25% Versus Olopatadine 0.2% in Allergic Conjunctivitis: Pooled Analysis of Two Multicenter Randomized Clinical Trials
- Medicine
- Advances in Therapy
- 2014
- 24
- PDF
Alcaftadine 0.25% versus Olopatadine 0.1% in Preventing Cedar Pollen Allergic Conjunctivitis in Japan: A Randomized Study
- Medicine
- Ocular immunology and inflammation
- 2018
- 3
Efficacy of Alcaftadine 0.25% (AGN-229666) for Once-daily Prevention of Cedar-Pollen Allergic Conjunctivitis: A Phase 3 Randomized Study.
- Medicine
- Ocular immunology and inflammation
- 2020